Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks

被引:154
作者
Philipp, M
Kohnen, R
Hiller, KO [1 ]
机构
[1] Steiner Arzneimittel, D-12207 Berlin, Germany
[2] Bezirkskrankenhaus Landshut, D-84034 Landstuhl, Germany
[3] Imerem Inst Med Res Management & Biometr, D-90478 Nurnberg, Germany
关键词
D O I
10.1136/bmj.319.7224.1534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To assess the efficacy and safety of hypericum extract (STEI 300, Steiner Arzneimittel, Berlin) compared with imipramine and placebo in patients in primary care with a current episode of moderate depression. Design Randomised, double blind, multicentre, parallel group trial for 8 weeks. Setting Trained panel of IS general practitioners from four German states: Bavaria Berlin, Rhineland Palatinate, and Saxony. Participants 263 patients (66 men, 197 women) with moderate depression according to ICD-10 (international classification of diseases, 10th revision) codes F32.1 and F33.1. Interventions 1050 mg hypericum extract (350 mg three times daily), 100 mg imipramine (50 mg, 25 mg, and 25 mg daily), or placebo three times daily Main outcome measures Change from baseline score on the It item version of the Hamilton depression scale, the Hamilton anxiety scale, the clinical global impressions scale, Zung's self rating depression scale, and SF-YB, and adverse events profile. Results Hypericum extract was more effective at reducing Hamilton depression scores than placebo and as effective as imipramine (mean - 15.4 (SD 8.1), -12.1 (7.4). and -14.2 (7.3) respectively). Comparable results were found for Hamilton anxiety and clinical global impressions scales and were most pronounced for the Zung self rating depression scale. Quality of life was more improved in the standardised mental component scale of the SF-36 with both active treatments than with placebo but in the physical component scale was improved only by hypericum extract compared with placebo. The rate of adverse events with hypericum extract was in the range of the placebo group but lower than that of the imipramine group (0.5, 0.6, and 1.2 events per patient respectively). Conclusions At an average dose of 350 mg three times daily hypericum extract was more effective than placebo and at least as effective as 100 mg imipramine daily in the treatment of moderate depression. Treatment with hypericum extract is safe and improves quality of life.
引用
收藏
页码:1534 / 1538
页数:5
相关论文
共 17 条
[1]  
Angst J, 1997, BMJ-BRIT MED J, V315, P1143
[2]  
[Anonymous], EUR NEUROPSYCHOPHARM, DOI DOI 10.1016/0924-977X(94)90093-0
[3]   Effectiveness of antidepressants - Meta-analysis of dose-effect relationships in randomised clinical trials [J].
Bollini, P ;
Pampallona, S ;
Tibaldi, G ;
Kupelnick, B ;
Munizza, C .
BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 :297-303
[4]   St John's wort as an antidepressant - Longer term studies are needed before it can be recommended in major depression [J].
DeSmet, PAGM ;
Nolen, WA .
BMJ-BRITISH MEDICAL JOURNAL, 1996, 313 (7052) :241-242
[5]   Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.) [J].
Ernst, E ;
Rand, JI ;
Barnes, J ;
Stevinson, C .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (08) :589-594
[6]  
*EUR COMM, 1998, CPMPICH36396 EUR COM
[7]  
*EUR COMM, 1990, NOT GUID MED PROD TR
[8]  
*EUR COMM, 1997, CPMPICH13595 EUR COM
[9]  
*GERM COMM, 1992, BUNDESANZEIGER 0808
[10]  
Heiligenstein J H, 1995, Int Psychogeriatr, V7 Suppl, P125, DOI 10.1017/S1041610295002407